Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,410 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, not recruiting

Hypofractionated LocoRegional Radiotherapy in Breast Cancer

NCT04228991

Conditions
Breast Diseases, Breast Neoplasms, Hemic and Lymphatic Diseases, +7 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BC Cancer - Centre for the North Prince George, British Columbia, Canada
View all 20 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

NCT04225117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
View all 39 locations
View Trial Details
Active, not recruiting

PALbociclib CoLlaborative Adjuvant Study

NCT02513394

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Southern Cancer Center PC - Providence Mobile, Alabama, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Cancer Center Anchorage, Alaska, United States
View all 437 locations
View Trial Details
Active, not recruiting

A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

NCT05629585

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
View all 276 locations
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

NCT04191499

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View all 135 locations
View Trial Details

Related conditions